We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Living Donors Boost Transplant Numbers

By HospiMedica staff writers
Posted on 29 Dec 2006
Almost one in three kidney transplants performed in the United Kingdom during 2005-2006 relied on the generosity of a living donor.

Data published by UK Transplant (Bristol, UK) revealed that 1,915 people received a lifesaving kidney transplant in 2006, of which 589 (31%) were given their kidney by a relative, partner, or friend. More...
UK Transplant's end-of-year figures also reveal a record 215 kidney transplants from non-heart-beating donors, an increase of 49% over the previous year. The rise in living and non-heart-beating donors contributed to a 3% increase in overall transplant numbers and helped compensate for a 4% decline in the number of heart-beating donors. Overall, 2,795 lives were saved or dramatically enhanced by an organ transplant, compared with 2,724 in 2005.

"During the last five years UK Transplant has invested more than £14 million in living and non-heartbeating donor programs, as well as other donor initiatives, at hospitals around the United Kingdom,” said Chris Rudge, UK Transplant managing director. "These are helping to provide the additional doctors and nurses needed to enable more people to donate, and the results are very encouraging.”

Despite the increase in transplant numbers, the need for donated organs continues to exceed those available. By the end of the 2006 financial year, 6,698 people were actively registered for a transplant, an increase of 9% over the 2005 financial year. The majority of patients (5,773) needed a kidney.

UK Transplant is the National Health Service (NHS) organization in the United Kingdom responsible for matching and allocating donated organs. It is part of NHS Blood and Transplant (NHSBT), a special health authority within the NHS that also manages the National Blood Service and the Bio Products Laboratory.



Related Links:
UK Transplant

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.